US4140698A
(en)
*
|
1977-07-25 |
1979-02-20 |
Syntex (Usa) Inc. |
1,2-Dihydro-3H-pyrrolo[1,2-a]pyrrole-1-nitriles
|
US4232038A
(en)
*
|
1979-08-31 |
1980-11-04 |
Syntex (U.S.A.) Inc. |
5-Alkylsulfinylbenzoyl- and 5-alkylsulfonylbenzoyl-1,2-dihydro-3H-pyrrolo[1,]pyrrole-1-carboxylic acids
|
US4410534A
(en)
*
|
1979-12-26 |
1983-10-18 |
Syntex (U.S.A.) Inc. |
3-Substituted-5,6,7,8-tetrahydropyrrolo[1,2-a]-pyridine-and 6,7,8,9-tetrahydro-5H-pyrrolo[1,2-a]-azepine carboxylic acid derivatives useful as blood platelet aggregation inhibitors
|
US4344943A
(en)
*
|
1980-06-09 |
1982-08-17 |
Syntex (U.S.A.) Inc. |
6-Chloro- or 6-bromo-1,2-dihydro-3H-pyrrolo[1,2-a]-pyrrole-1-carboxylic acids and derivatives thereof
|
US4456759A
(en)
*
|
1980-10-20 |
1984-06-26 |
Syntex (U.S.A.) Inc. |
5-Benzoyl-7-halo-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1,1-dicarboxylic acids and esters thereof
|
US4347187A
(en)
*
|
1980-10-20 |
1982-08-31 |
Syntex (U.S.A.) Inc. |
Process for preparing 5-aroyl 1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acids and novel intermediates therein
|
US4347186A
(en)
*
|
1980-10-20 |
1982-08-31 |
Syntex (U.S.A.) Inc. |
Process for preparing 5-aroyl 1,2-dihydro-3-H pyrrolo[1,2-a]pyrrole-1-carboxylic acids and novel intermediates therein
|
US4353829A
(en)
*
|
1980-11-21 |
1982-10-12 |
Syntex (U.S.A.) Inc. |
Process for 5-aroylation of 1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic esters
|
WO1983001382A1
(en)
*
|
1981-10-13 |
1983-04-28 |
Mroszczak, Edward |
Gastrointestinal sparing thioester pro-drugs
|
US4454151A
(en)
*
|
1982-03-22 |
1984-06-12 |
Syntex (U.S.A.) Inc. |
Use of pyrrolo pyrroles in treatment of ophthalmic diseases
|
US4457941A
(en)
*
|
1982-03-22 |
1984-07-03 |
Syntex (U.S.A.) Inc. |
Use of pyrrolo-pyrrole in treating microvascular diseases associated with diabetes
|
US4560699A
(en)
*
|
1983-01-17 |
1985-12-24 |
Syntex (U.S.A.) Inc. |
5-(4-Vinylbenzoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]-pyrrole-1-carboxylic acids and derivatives thereof and use as analgesics and anti-inflammatories
|
US4496741A
(en)
*
|
1983-01-24 |
1985-01-29 |
Merck & Co., Inc. |
Process for the preparation of 5-aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivative
|
EP0117675B1
(en)
*
|
1983-02-19 |
1986-07-23 |
Beecham Group Plc |
Benzofuran and benzothiophene-carboxylic-acid derivatives
|
US4622407A
(en)
*
|
1984-04-26 |
1986-11-11 |
Merck & Co., Inc. |
Resolution of racemic derivatives of 5-(1-methyl-5-methylthiopyrrol-2-oyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-2-carboxylic acid and analogs
|
US4988822A
(en)
*
|
1986-05-29 |
1991-01-29 |
Syntex (U.S.A.) Inc. |
Intermediates for preparing 5-aroyl-1,2-dihydro-3H-pyrrolo(1,2-A)pyrrole-1,1-dicarboxylates
|
US4873340A
(en)
*
|
1986-05-29 |
1989-10-10 |
Syntex (U.S.A.) Inc. |
Process for preparing 5-aroyl-1,2-dihydro-3H-pyrrolo[1,2-A]pyrrole-1,1-dicarboxylates
|
US4937368A
(en)
*
|
1987-01-14 |
1990-06-26 |
Syntex (U.S.A.) Inc. |
Process for preparing (+)-2,3-dihydro-1H-pyrrolo[1,2-A]pyrrole-1,7-dicarboxylates
|
HU198927B
(en)
*
|
1987-01-14 |
1989-12-28 |
Richter Gedeon Vegyeszet |
Process for producing 1-/substituted aminomethyl/-octa-hydroindolo-(2,3-a)quinolizine derivatives, pharmaceutically applicable acid addition salts thereof, as well as pharmaceutical compositions comprising same
|
US4874872A
(en)
*
|
1987-01-14 |
1989-10-17 |
Syntex (U.S.A.) Inc. |
Process for preparing (+)-2,3-dihydro-1H-pyrrolo[1,2-A]pyrrole-1,7-dicarboxylates
|
US4835288A
(en)
*
|
1987-01-14 |
1989-05-30 |
Syntex Inc. |
Process for preparing (+)-2,3-dihydro-1H-pyrrolo[1,2-a]pyrrole-1,7-dicarboxylates
|
US4874871A
(en)
*
|
1987-03-25 |
1989-10-17 |
Syntex (U.S.A.) Inc. |
Process for preparing (+)-2,3-Dihydro-1H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid and related compounds
|
US5414011A
(en)
*
|
1987-09-11 |
1995-05-09 |
Syntex (U.S.A.) Inc. |
Preservative system for ophthalmic formulations
|
US5110493A
(en)
*
|
1987-09-11 |
1992-05-05 |
Syntex (U.S.A.) Inc. |
Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
|
JPH02502534A
(ja)
*
|
1987-12-18 |
1990-08-16 |
チバ‐ガイギー アクチェンゲゼルシャフト |
1‐メチル‐β‐オキソ‐α‐(フェニルカルバモイル)‐2‐ピロールプロピオニトリルのトロメタミン塩
|
US5464609A
(en)
*
|
1990-03-16 |
1995-11-07 |
The Procter & Gamble Company |
Use of ketorolac for treatment of oral diseases and conditions
|
IT1241124B
(it)
*
|
1990-04-20 |
1993-12-29 |
Industriale Chimica |
Processo per la preparazione di derivati di acidi 1,2-diidro 3h pirrol (1,2-a) pirrol-l-carbossilici e relativi intermedi
|
US5091182A
(en)
*
|
1990-07-23 |
1992-02-25 |
Syntex (U.S.A.) Inc. |
Dispensing units for ketorolac topical gel formlations
|
US5082951A
(en)
*
|
1990-10-12 |
1992-01-21 |
Syntex (U.S.A.) Inc. |
Process for preparing 5-aroyl-2,3-dihydro-1H-pyrrolizine-1,1-dicarboxylates (I) and intermediates therefor
|
US5082950A
(en)
*
|
1990-10-12 |
1992-01-21 |
Syntex (U.S.A.) Inc. |
Process for preparing 5-aroyl-2,3-dihydro-1H-pyrrolizine-1,1-dicarboxylates (II) and intermediates therefor
|
IT1250691B
(it)
|
1991-07-22 |
1995-04-21 |
Giancarlo Santus |
Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
|
JP2902113B2
(ja)
*
|
1991-11-11 |
1999-06-07 |
久光製薬株式会社 |
ケトロラク含有シップ剤
|
US5474994A
(en)
*
|
1992-05-26 |
1995-12-12 |
Recordati S.A., Chemical And Pharmaceutical Company |
Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A
|
US5605896A
(en)
*
|
1992-02-25 |
1997-02-25 |
Recordati S.A., Chemical And Pharmaceutical Company |
Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities
|
IT1258315B
(it)
*
|
1992-04-10 |
1996-02-22 |
Recordati Chem Pharm |
Derivati del flavone
|
US5883115A
(en)
*
|
1992-11-09 |
1999-03-16 |
Pharmetrix Division Technical Chemicals & Products, Inc. |
Transdermal delivery of the eutomer of a chiral drug
|
DE69333009T2
(de)
*
|
1992-11-09 |
2003-12-04 |
Neurogesx, Inc. |
Transdermale verabreichung von ketorolac
|
US5382591A
(en)
*
|
1992-12-17 |
1995-01-17 |
Sepracor Inc. |
Antipyretic and analgesic methods using optically pure R-ketorolac
|
DE4300697C1
(de)
*
|
1993-01-13 |
1994-05-19 |
Roemmers Sa |
Keterolac-Derivat mit wesentlich geringerer gastrointestinaler Reizung und Ulzeration
|
US5591767A
(en)
*
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
EP0707465A4
(en)
*
|
1993-07-08 |
1997-04-16 |
Cygnus Therapeutic Systems |
MONOLITHIC MATRIX TRANSDERMAL DELIVERY SYSTEM
|
KR0140134B1
(ko)
*
|
1994-11-16 |
1998-06-01 |
강재헌 |
피롤리진 유도체의 제조방법
|
US5622948A
(en)
*
|
1994-12-01 |
1997-04-22 |
Syntex (U.S.A.) Inc. |
Pyrrole pyridazine and pyridazinone anti-inflammatory agents
|
US5767136A
(en)
*
|
1995-05-12 |
1998-06-16 |
Recordati, S.A. Chemical And Pharmaceutical Company |
1,4-Dihydropyridines useful for prevention or reduction of atherosclerotic lesions on arterial walls
|
US5696139A
(en)
*
|
1995-05-12 |
1997-12-09 |
Recordati S.A., Chemical And Pharmaceutical Company |
Use of S-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure
|
US5621115A
(en)
*
|
1996-02-21 |
1997-04-15 |
Ohmeda Pharmaceutical Products Division Inc. |
Methods for preparing 5-aroyl-1,2-dihydro-3H-pyrrolo-[1,2-A]pyrrole-1-carboxylic acids
|
TR199802456T2
(xx)
*
|
1996-05-30 |
1999-02-22 |
F.Hoffmann-La Roche Ag |
Yeni pirol t�revleri.
|
US6191285B1
(en)
|
1997-07-03 |
2001-02-20 |
Abbott Laboratories |
Process for the preparation of ketorolac tromethamine
|
ATE323703T1
(de)
*
|
1998-07-10 |
2006-05-15 |
Mallinckrodt Inc |
Synthese von verbindungen die zur herstellung von ketorolac dienen
|
US6197976B1
(en)
|
1998-12-14 |
2001-03-06 |
Syntex (U.S.A.) Llc |
Preparation of ketorolac
|
IT1308633B1
(it)
|
1999-03-02 |
2002-01-09 |
Nicox Sa |
Nitrossiderivati.
|
US6306861B1
(en)
|
1999-07-30 |
2001-10-23 |
Recordati S.A. Chemical And Pharmaceutical Company |
Thienopyrancecarboxamide derivatives
|
US6387909B1
(en)
|
1999-07-30 |
2002-05-14 |
Recordati S.A. Chemical And Pharmaceutical Company |
Thienopyranecarboxamide derivatives
|
US6552020B1
(en)
*
|
1999-07-30 |
2003-04-22 |
Allergan, Inc. |
Compositions including antibiotics and methods for using same
|
US6403594B1
(en)
|
1999-10-18 |
2002-06-11 |
Recordati, S.A. Chemical And Pharmaceutical Company |
Benzopyran derivatives
|
US6365591B1
(en)
|
1999-10-18 |
2002-04-02 |
Recordati, S.A., Chemical And Pharmacueticals Company |
Isoxazolecarboxamide derivatives
|
CA2406383A1
(en)
*
|
2000-04-13 |
2001-10-25 |
Mayo Foundation For Medical Education And Research |
A.beta.42 lowering agents
|
ES2392636T3
(es)
|
2000-07-14 |
2012-12-12 |
Allergan, Inc. |
Composiciones que contienen componentes terapéuticamente activos que tienen solubilidad mejorada
|
IT1318674B1
(it)
*
|
2000-08-08 |
2003-08-27 |
Nicox Sa |
Faramaci per l'incontinenza.
|
IT1318673B1
(it)
*
|
2000-08-08 |
2003-08-27 |
Nicox Sa |
Farmaci per le disfunzioni sessuali.
|
US20030027867A1
(en)
*
|
2001-06-29 |
2003-02-06 |
Myriad Genetics, Incorporated |
Use of R-NSAID compounds for anti-HIV treatment
|
KR100400885B1
(ko)
*
|
2001-07-20 |
2003-10-17 |
경동제약 주식회사 |
라세미체의 케토로락을 단일이성체로 분리하는 방법
|
US20030191187A1
(en)
*
|
2002-04-01 |
2003-10-09 |
Lee Fang Yu |
Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same
|
EP1603548A4
(en)
*
|
2003-02-05 |
2007-10-10 |
Myriad Genetics Inc |
COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS
|
US20040191332A1
(en)
*
|
2003-03-27 |
2004-09-30 |
Allergan, Inc. |
Preserved ophthalmic compositions
|
BRPI0302736B8
(pt)
|
2003-06-02 |
2021-05-25 |
Ems S/A |
composição farmacêutica a base de cetorolaco ou de um de seus sais farmaceuticamente aceitáveis para uso sublingual
|
US8008338B2
(en)
|
2003-06-03 |
2011-08-30 |
Allergan, Inc. |
Ketorolac tromethamine compositions for treating or preventing ocular pain
|
EP1651195A4
(en)
*
|
2003-07-11 |
2007-10-03 |
Myriad Genetics Inc |
PHARMACEUTICAL PROCESSES, DOSIERSCHEMATA AND DOSAGE FORMS FOR THE TREATMENT OF ALZHEIMER DISEASE
|
WO2005014046A2
(en)
*
|
2003-08-07 |
2005-02-17 |
Allergan, Inc. |
Compositions for delivery of therapeutics into the eyes and methods for making and using the same
|
US20050171207A1
(en)
*
|
2003-09-26 |
2005-08-04 |
Myriad Genetics, Incorporated |
Method and composition for combination treatment of neurodegenerative disorders
|
US20070293538A1
(en)
*
|
2004-04-13 |
2007-12-20 |
Myriad Genetics, Incorporated |
Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
|
AU2005241023A1
(en)
*
|
2004-04-29 |
2005-11-17 |
Keystone Retaining Wall Systems, Inc. |
Veneers for walls, retaining walls and the like
|
WO2006020852A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
WO2006020850A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
CA2618985A1
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
KR20070091682A
(ko)
*
|
2004-12-23 |
2007-09-11 |
록스로 파마 인코퍼레이티드 |
케토롤락의 비내 투여용 치료 조성물
|
US20070015832A1
(en)
*
|
2005-07-14 |
2007-01-18 |
Myriad Genetics, Incorporated |
Methods of treating overactive bladder and urinary incontinence
|
WO2007014124A2
(en)
*
|
2005-07-22 |
2007-02-01 |
Myriad Genetics, Inc. |
High drug load formulations and dosage forms
|
WO2007146795A2
(en)
*
|
2006-06-12 |
2007-12-21 |
Ironwood Pharmaceuticals, Inc. |
Pharmaceutical formulation for parenteral administration
|
US20080033045A1
(en)
*
|
2006-07-07 |
2008-02-07 |
Myriad Genetics, Incorporated |
Treatment of psychiatric disorders
|
US7842714B2
(en)
*
|
2008-03-03 |
2010-11-30 |
Allergan, Inc. |
Ketorolac tromethamine compositions for treating ocular pain
|
US9192571B2
(en)
*
|
2008-03-03 |
2015-11-24 |
Allergan, Inc. |
Ketorolac tromethamine compositions for treating or preventing ocular pain
|
WO2009152369A1
(en)
*
|
2008-06-13 |
2009-12-17 |
Roxro Pharma, Inc. |
Pharmaceutical formulation of ketorolac for intranasal administration
|
US8551454B2
(en)
*
|
2009-03-13 |
2013-10-08 |
Luitpold Pharmaceuticals, Inc. |
Device for intranasal administration
|
US8277781B2
(en)
*
|
2009-03-13 |
2012-10-02 |
Luitpold Pharmaceuticals, Inc. |
Device for intranasal administration
|
CA2796041A1
(en)
|
2010-04-07 |
2011-10-13 |
Allergan, Inc. |
Combinations of preservative compositions for ophthalmic formulations
|
EP2555748A2
(en)
|
2010-04-07 |
2013-02-13 |
Allergan, Inc. |
Combinations of preservatives for ophthalmic compositions
|
KR20190085561A
(ko)
|
2010-10-21 |
2019-07-18 |
알티유 파머수티컬즈, 엘엘시 |
즉시 사용가능한 케토로락 제제
|
WO2012127497A1
(en)
|
2011-03-04 |
2012-09-27 |
Cadila Healthcare Limited |
Stable pharmaceutical compositions of ketorolac or salts thereof
|
CA2991391A1
(en)
|
2017-01-09 |
2018-07-09 |
Steadymed, Ltd. |
Dose sparing ketorolac formulations and methods and devices for use withsame
|
US20180193460A1
(en)
|
2017-01-09 |
2018-07-12 |
Steadymed, Ltd. |
Enhanced stability ketorolac formulations and methods and devices for use with same
|
UA126916C2
(uk)
|
2017-04-27 |
2023-02-22 |
Др. Редді'З Лабораторіз Лімітед |
Фармацевтична композиція кеторолаку
|
MX2018000963A
(es)
|
2018-01-22 |
2018-12-13 |
Federico Amezcua Amezcua |
Composicion farmaceutica sinergica del enantiomero activo s-ketorolaco trometamina y clorhidrato de tramadol.
|
JP7229012B2
(ja)
*
|
2018-12-25 |
2023-02-27 |
小林製薬株式会社 |
内服用医薬組成物
|
MX2019008467A
(es)
|
2019-07-16 |
2019-11-07 |
Federico Amezcua Amezcua |
Combinacion sinergica de s-ketorolaco y pregabalina en una composicion farmaceutica para el tratamiento del dolor neuropatico.
|